# Dimitrios L. Wagner

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/dimitrios-l-wagner/

## Facts

| Field | Value |
| --- | --- |
| Citations | 3,433 |
| Field | CAR-T cell therapy research |
| h-index | 20 |
| i10-index | 27 |
| Last Known Institution | Baylor College of Medicine |
| OpenAlex ID | https://openalex.org/A5002084661 |
| ORCID iD | 0000-0002-2189-3579 |
| Works | 93 |

## Researcher papers

- [Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours](https://scholariq.org/papers/overcoming-on-target-off-tumour-toxicity-of-car-t-cell-therapy-for-solid-tumours/)
- [CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies](https://scholariq.org/papers/cd7-edited-t-cells-expressing-a-cd7-specific-car-for-the-therapy-of-t-cell/)
- [High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population](https://scholariq.org/papers/high-prevalence-of-streptococcus-pyogenes-cas9-reactive-t-cells-within-the-adult/)
- [Immunogenicity of CAR T cells in cancer therapy](https://scholariq.org/papers/immunogenicity-of-car-t-cells-in-cancer-therapy/)
- [Constitutive Signaling from an Engineered IL7 Receptor Promotes Durable Tumor Elimination by Tumor-Redirected T Cells](https://scholariq.org/papers/constitutive-signaling-from-an-engineered-il7-receptor-promotes-durable-tumor/)
- [Highly Efficient Genome Editing of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9](https://scholariq.org/papers/highly-efficient-genome-editing-of-murine-and-human-hematopoietic-progenitor/)
- [CAR T-cells that target acute B-lineage leukemia irrespective of CD19 expression](https://scholariq.org/papers/car-t-cells-that-target-acute-b-lineage-leukemia-irrespective-of-cd19-expression/)
- [Regulatory T cells for minimising immune suppression in kidney transplantation: phase I/IIa clinical trial](https://scholariq.org/papers/regulatory-t-cells-for-minimising-immune-suppression-in-kidney-transplantation/)
- [Pharmacological interventions enhance virus-free generation of TRAC-replaced CAR T cells](https://scholariq.org/papers/pharmacological-interventions-enhance-virus-free-generation-of-trac-replaced-car/)
- [PAX5 biallelic genomic alterations define a novel subgroup of B-cell precursor acute lymphoblastic leukemia](https://scholariq.org/papers/pax5-biallelic-genomic-alterations-define-a-novel-subgroup-of-b-cell-precursor/)
- [Torsemide Versus Furosemide After Continuous Renal Replacement Therapy Due to Acute Renal Failure in Cardiac Surgery Patients](https://scholariq.org/papers/torsemide-versus-furosemide-after-continuous-renal-replacement-therapy-due-to/)

## Researcher topics

- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [CRISPR and Genetic Engineering](https://scholariq.org/topics/crispr-and-genetic-engineering/)
- [Virus-based gene therapy research](https://scholariq.org/topics/virus-based-gene-therapy-research/)
- [Immune Cell Function and Interaction](https://scholariq.org/topics/immune-cell-function-and-interaction/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Researcher university

- [Baylor College of Medicine](https://scholariq.org/institutions/baylor-college-of-medicine/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.